←
Romix Biosciences9 posts
Romix Biosciences avatar✓

Romix Biosciences ✓

@romixbio

Molecular intelligence for precision medicine

◷ Joined March 2026
Markus J. Buehler avatar
⟳ Romix Biosciences retweeted
Markus J. Buehler@ProfBuehlerMIT·Oct 29

We're one day away from our ScienceClaw Hackathon - see you all tomorrow afternoon Oct 30, 2026 at the @MIT @medialab for an exciting weekend. Thank you to our sponsors @nvidia , @claudeai, @formlabs, @nebiusai, @EdisonSci, @Stifel Venture Banking, @Google, @romixbio, @askalphaxiv, the @MITEngineering, and @LilaSciences for supporting the event and providing resources for our teams. A dream team of leaders in agentic AI, AI for science, and scaling discovery! And thank you to our amazing organizing team Habib Haddad, Calvin Chin, @e14fund, Andrea Porras, @fwang108_, @JaimeBerkovich, @SubhadeepPal, Bruno Howard, Awu Chen, Keira Boone, @leemmarom, and @maxwellbauer, and to our judges @evijit, Desiree Plata, Yilun Du, Riken Shah, Ian Ferguson, and @NikitaFedik for contributing their time and expertise. We are also grateful to the broader community joining us from Hardmode, Sundai, Harvard University, the University of Michigan, MIT, and @ReactorfieldAI, bringing together expertise and perspectives across institutions and disciplines. Looking forward to seeing what we build together!

1:14
Patrick Collison avatar
⟳ Romix Biosciences retweeted
Patrick Collison@patrickc·Aug 20

The 2026 @arcinstitute Virtual Cell Challenge just launched. The grand prize is $100,000, sponsored by @NVIDIA, @10xGenomics, and @UltimaGenomics. There's a lot of interest in virtual cells these days: ML models of cells that can complement wet lab experiments. (You'll always need the wet lab to validate results, of course. But ML models can in principle search far more efficiently.) A practical challenge in the field is that benchmarking is quite difficult: cells are very complicated, and it's not a priori obvious how to compare two different models. So, inspired by the CASP protein folding contest, we're running the Virtual Cell Challenge to create a standardized way for teams around the world to compare the efficacy of different approaches, to spread awareness of what works, and ultimately -- we hope -- to support faster progress overall. arcinstitute.org/news/virtua…

Romix Biosciences avatar
Romix Biosciences@romixbio·Aug 18

Grant: Funded! Romix Bio has been awarded a Phase II SBIR from NHLBI! This grant supports our partnership with leading medical centers to apply our cfRNA×AI platform to Kawasaki disease, continuing our CEO @LoyConor's work from his time at @CornellBME

Cornell Biomedical Engineering avatar
⟳ Romix Biosciences retweeted
Cornell Biomedical Engineering@CornellBME·Jun 8

In May, Cornell CAT brought together researchers, industry leaders and investors to accelerate life sciences innovation. Biomedical engineering faculty helped showcase technologies and partnerships that can move discoveries toward real-world impact. news.cornell.edu/stories/202…

Post attachment
Iwijn De Vlaminck avatar
⟳ Romix Biosciences retweeted
Iwijn De Vlaminck@IwijnDeVlaminck·Mar 25

CAR-T is effective for B cell lymphoma, but not for all patients. RNA profiling of the tumor microenvironment can inform response, but requires biopsies. We ask whether TME signals can be detected in blood via cell-free RNA. The data are encouraging: medrxiv.org/content/10.64898…